Contact information
Type
Scientific
Primary contact
Dr Vladimir Poznyak
ORCID ID
Contact details
World Health Organization (WHO)
20 Avenue Appia
Geneva-27
CH-1211
Switzerland
poznyak@who.int
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
RPC024
Study information
Scientific title
Acronym
ASSIST
Study hypothesis
Not provided at time of registration
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Not Specified
Patient information sheet
Condition
Substance abuse
Intervention
1. Both groups: ASSIST and a demographic profile questionnaire
2. Intervention group: brief intervention for the drug scoring highest on ASSIST and related self-help materials
3. Control group: on waitlist and brief intervention at 3 months follow-up
Intervention type
Other
Phase
Phase III
Drug names
Primary outcome measures
Not provided at time of registration
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/01/2005
Overall trial end date
31/12/2005
Reason abandoned
Eligibility
Participant inclusion criteria
1. Age 18 - 50 years
2. Member of main ethnic group in the population
3. Able to communicate in the national language
4. Willing for three month follow-up
5. Be able to be followed up three months later and give contact details of two to three other people
6. Have a fixed address and provide contact details of their home
Participant type
Patient
Age group
Adult
Gender
Not Specified
Target number of participants
1047
Participant exclusion criteria
1. Any pending court session with possible incarceration within three months
2. Any severe intellectual disability or cognitive impairment
3. Severe behaviour disturbance or psychotic symptoms
4. Tendencies to violent or aggressive behaviour
5. Intoxicated or withdrawal from alcohol or drugs
6. Incarcerated or in the environment with no free movements in the last three months
Recruitment start date
01/01/2005
Recruitment end date
31/12/2005
Locations
Countries of recruitment
Australia, Brazil, India, Spain, Thailand, United States of America
Trial participating centre
World Health Organization (WHO)
Geneva-27
CH-1211
Switzerland
Sponsor information
Organisation
World Health Organization (WHO)/The Department of Mental Health and Substance Abuse (MSD) (Switzerland)
Sponsor details
20
Avenue Appia
Geneva-27
CH 1211
Switzerland
Sponsor type
Research organisation
Website
Funders
Funder type
Research organisation
Funder name
World Health Organization (WHO)/The Department of Mental Health and Substance Abuse (MSD) (Switzerland)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
2008 results in http://www.ncbi.nlm.nih.gov/pubmed/18373724
Publication citations
-
Results
Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, de Lacerda RB, Ling W, Marsden J, Monteiro M, Nhiwatiwa S, Pal H, Poznyak V, Simon S, Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST)., Addiction, 2008, 103, 6, 1039-1047, doi: 10.1111/j.1360-0443.2007.02114.x.